Raia Drogasil (OTCMKTS:RADLY – Get Free Report) is anticipated to announce its results before the market opens on Tuesday, March 3rd. Analysts expect the company to announce earnings of $0.0388 per share and revenue of $2.2769 billion for the quarter.
Raia Drogasil Price Performance
RADLY opened at $5.00 on Monday. The company has a 50-day moving average of $4.74 and a 200-day moving average of $4.12. Raia Drogasil has a 1-year low of $2.17 and a 1-year high of $5.34.
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Recommended Stories
- Five stocks we like better than Raia Drogasil
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- America’s 1776 happening again
- Unlocked: Elon Musk’s Next Big IPO
- Silver paying 20% dividend. Plus 68% share gains
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
